Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

فلترة النتائج

Publisher : ferrata storti foundation Format : Academic Journals Subject : multiple myeloma Subject : terapia celular فلترة بواسطة : مؤلف

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex.

Authors : Zhou X; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg.; Besse A

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology; Humans ; Proteasome Endopeptidase Complex

Source: Haematologica [Haematologica] 2023 Jun 01; Vol. 108 (6), pp. 1628-1639. Date of Electronic Publication: 2023 Jun 01.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Report

IKZF1/3 and CRL4 CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma.

Authors : Barrio S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.; Munawar U

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics ; Pharmaceutical Preparations*

Source: Haematologica [Haematologica] 2020 May; Vol. 105 (5), pp. e237-e241. Date of Electronic Publication: 2019 Sep 26.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي